SCN2A基因多态性对汉族儿童症药物反应的影响
Lin Xu1, Jie Fan2, Yongbiao Zou2
1Department of Pediatrics, Brain Hospital of Hunan Province (The Second People's Hospital of Hunan Province), College of Clinical Medicine, Hunan University of Chinese Medicine.
The Tohoku journal of experimental medicine
|May 28, 2025
概括
在SCN2A基因 (rs2121371和rs1864885) 的遗传变异影响药物的有效性和儿童的不良反应. 这些SCN2A多态可能会影响治疗结果和肝损伤风险.
科学领域:
- 遗传学 是一个遗传学.
- 神经学 神经学
- 药物基因组学 药物基因组学
背景情况:
- 儿童是一种常见的神经疾病,影响儿童发育.
- 治疗的疗效各不相同,遗传因素也可能起作用.
- 电压通道α子单元2基因 (SCN2A) 与神经功能有关.
研究的目的:
- 调查SCN2A基因多态性 (rs2121371和rs1864885) 对药物的疗效的影响.
- 探索这些SCN2A多态化与不良药物反应 (包括肝损伤) 之间的关联.
主要方法:
- 在98名儿科患者中使用聚合酶链反应进行SCN2A rs2121371和rs1864885的基因定型.
- 根据药物反应将患者分为没有发作和发作的组.
- 根据药物诱导的肝损伤的存在或不存在来对患者进行分类.
- 后勤回归分析以确定多态和临床结果之间的相关性.
主要成果:
- 在发作组之间观察到rs2121371和rs1864885的等位基因频率的显著差异.
- rs2121371的C等位基因和CC基因型与不良药物反应相关 (P = 0.004,P = 0.013).
- rs1864885的G等位基因和AG基因型与不良药物反应有关 (P < 0.001).
- rs2121371的多态性与药物诱导的肝损伤相关,而rs1864885没有显示这种关联.
结论:
- SCN2A基因多态 rs2121371和rs1864885可能会影响儿童治疗的疗效.
- 这些SCN2A变异与不良药物反应有关,对于rs2121371,与肝损伤有关.
- 这些发现表明,在个性化治疗策略中,SCN2A基因型定型的潜力很大.
相关概念视频
01:29Drug Dosing: Infants and Children
324
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
324
01:30Combined Effects of Drugs: Antagonism
11.8K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.8K
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
859
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
859
01:27Combined Effects of Drugs: Synergism
7.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.0K
01:21Factors Affecting Drug Response: Overview
3.1K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K
01:05Single Nucleotide Polymorphisms-SNPs
18.6K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.6K